Please login to the form below

Not currently logged in
Email:
Password:

PwC appoints Issy Corbett as healthcare M&A partner

He brings experience from the Rothschild Group

PwC Issy CorbettPricewaterhouseCoopers has appointed Issy Corbett as its new healthcare mergers & acquisitions partner.

He joins the professional services firm from Rothschild where he has spent the last ten years working on healthcare accounts in the UK and Europe.

Andrew McKechnie, partner and head of healthcare deals at PwC, said: “Issy's experience and reputation in healthcare M&A is market-leading.

“Together, our healthcare deals practice will offer clients a full suite of healthcare advisory services across a deal lifecycle.”

In his new role, Corbett will lead PwC's healthcare M&A team, working with the company's public sector advisory, strategy and transaction services across both UK regional and international offices.

Corbett said: “I am very excited and proud to join a firm of PwC's global reputation to reinforce its healthcare M&A business at what is such an vibrant time for the industry.”

4th February 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics